drugset / Trial / NCT04727086

Role of BP1.3656 on Alcohol Responses

NCT04727086 ↗

Phase 2 Completed 37 enrolled Centre for Addiction and Mental Health
RandomizedCrossoverQuadruple-blindOther

Summary

The current study will determine whether a novel pharmacotherapy, BP1. 3656, affects laboratory alcohol self-administration in participants with alcohol use disorder (AUD).

Timeline

Start
2021-02-01
Primary completion
2022-08-31
Completion
2022-08-31

Drugs

EvaluationDrugModalityDoseRoute
Subject BP1.3656 Unknown 60 ug Oral

Indications